Metraipolis › archive › dc_fa27da6cc86f

KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC — Europe PMC PMID:41001026

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41001026
DOI
10.3389/fonc.2025.1654491
License (as archived)
solo-consultazione
Archived
2026-11-10T00:56:22.790Z
SHA-256 of the archived text
9f4366e09f3ecd91c277bfc4e795015ebfb9ecc06b1c7212486db5df256f6829
Stable URL of this page
https://metraipolis.com/documento/dc_fa27da6cc86f

How to cite

KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC — Europe PMC PMID:41001026 — Europe PMC (en), https://europepmc.org/article/MED/41001026 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fa27da6cc86f (Metraipolis archive dc_fa27da6cc86f, sha256 9f4366e09f3ecd91c277bfc4e795015ebfb9ecc06b1c7212486db5df256f6829)
BibTeX
@misc{dcfa27da6cc86f,
  title = {KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC — Europe PMC PMID:41001026},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41001026},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fa27da6cc86f; sha256 9f4366e09f3ecd91c277bfc4e795015ebfb9ecc06b1c7212486db5df256f6829},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41001026. Agents can read the archived copy with the MCP tool read_document.